The International Journal of Romanian Society of Endocrinology / Registered in 1938

in ISI Thomson Master Journal List

October - December 2018, Volume 14, Issue 4
Case Report

Matulevicius V, Urbanavicius V, Lukosevicius S, Ciaplinskiene L, Ostrauskas R

The Rare Case of Mixed Gonadal Dysgenesis, Mosaic Karyotype, Petroclival Meningioma and Idiopathic Hyperdehydroepiandrosteronism

Acta Endo (Buc) 2018, 14 (4): 527-532
doi: 10.4183/aeb.2018.527

Background. Mosaic karyotype 45,X/46,XY related mixed gonadal dysgenesis. Aim. To report a case of mosaic karyotype and petroclival meningioma. Methods. Presentation of a clinical case with comments. Results. The case of a 37-year-old woman mosaic karyotype - 45,X/46,XY, infertility, virilisation, Turner syndrome-like phenotype, primary amenorrhea, the absence of labia majora and petroclival meningioma. Concentrations of dehydroepiandrosterone sulphate (DHEAS), testosterone, luteinizing hormone (LH) and follicular stimulating hormone (FSH) were increased indicating hypergonadotropic hypogonadism. Low and high dose dexamethasone suppression tests demonstrated incomplete suppression of DHEAS concentration without connection between pulses of LH/FSH and DHEAS. Response to adrenocorticotropic hormone (ACTH) was normal. The morning/evening concentration ratio of DHEAS was very low in comparison with cortisol, ACTH and testosterone. Head magnetic resonance imaging (MRI) demonstrated petroclival meningioma without any adrenal or ovary abnormality. Menstruation started after treatment with 2 mg of estradiol. At control visit 1.5 years later she had no complaints. MRI did not demonstrate any signs of tumour progression. Conclusions. The main lesson learned from this case is that in searching the DHEAS secreting tumours one can find unusual cases with sustained high DHEAS and lack of confirmations of polycystic ovary syndrome, adrenal or ovary tumours using available ultrasound, CT and MRI.

Keywords: Mixed gonadal dysgenesis, chromosomal mosaicism, dehydroepiandrosterone sulphate

Correspondence: Valentinas Matulevicius MD, Lithuanian University of Health Sciences, Institute of Endocrinology, Eiveniu 2, Kaunas, 50009, Lithuania, E-mail: